Delay treating patient more than likely advanced his prostate cancer, report says

Watchdog finds failings in prostate cancer treatment in North Wales going back almost a decade.

Guidehouse, IP3, and Cybernetic Intelligence Form Strategic Partnership to Develop Nuclear‑Powered Compute Infrastructure

Guidehouse, IP3 Corporation, and Cybernetic Intelligence have partnered to jointly advance a new class of secure, resilient, nuclear‑enabled compute infrastructure. The partnership brings together ...

Johnson & Johnson: FDA approval of ICOTYDE (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide

Johnson & Johnson introduces the first and only IL-23R targeted oral peptide that delivers complete skin clearance and favorable safety profile in a once-daily pill ICOTYDE ...